Retrospective Study of MRI in Pediatric Patients

NCT02291822 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 90

Last updated 2016-07-19

No results posted yet for this study

Summary

Collection of already existing data and images for patients \< 2 years of age having MultiHance administration for a MRI of the brain or spine. MR Images will be reviewed during a prospectively designed blinded reading of the images.

Conditions

  • Central Nervous System Disease
  • Central Nervous System Neoplasms

Interventions

DRUG

Gadobenate Dimeglumine

gadolinium contrast agent

Sponsors & Collaborators

  • Bracco Diagnostics, Inc

    lead INDUSTRY

Principal Investigators

  • Gianpaolo Priovano, M.D. · Bracco Diagnostics, Inc

Eligibility

Max Age
2 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-11-30
Primary Completion
2015-12-31
Completion
2015-12-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02291822 on ClinicalTrials.gov